Nuvectis Pharma, Inc.NVCTNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-45.13%
↑ 97% above average
Average (18q)
-1373.45%
Historical baseline
Range
High:46.15%
Low:-26011.11%
Volatility
-1897.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -45.13% |
| Q2 2025 | -11.11% |
| Q1 2025 | 20.59% |
| Q4 2024 | -41.67% |
| Q3 2024 | 7.69% |
| Q2 2024 | -4.00% |
| Q1 2024 | 40.48% |
| Q4 2023 | -13.51% |
| Q3 2023 | 2.63% |
| Q2 2023 | -40.74% |
| Q1 2023 | 46.00% |
| Q4 2022 | -19.05% |
| Q3 2022 | -50.00% |
| Q2 2022 | 12.50% |
| Q1 2022 | -52.38% |
| Q4 2021 | 46.15% |
| Q3 2021 | 17.02% |
| Q2 2021 | -26011.11% |
| Q1 2021 | 0.00% |